- Home
- GTEC vs ANEB Comparison
GTEC vs ANEB Comparison
Compare GTEC & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- ANEB
- Stock Information
- Founded
- GTEC 2006
- ANEB 2020
- Country
- GTEC United States
- ANEB United States
- Employees
- GTEC N/A
- ANEB N/A
- Industry
- GTEC Industrial Machinery/Components
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- ANEB Health Care
- Exchange
- GTEC Nasdaq
- ANEB Nasdaq
- Market Cap
- GTEC 21.2M
- ANEB 111.8M
- IPO Year
- GTEC N/A
- ANEB 2021
- Fundamental
- Price
- GTEC $1.16
- ANEB $2.75
- Analyst Decision
- GTEC
- ANEB Buy
- Analyst Count
- GTEC 0
- ANEB 2
- Target Price
- GTEC N/A
- ANEB $8.00
- AVG Volume (30 Days)
- GTEC 142.7K
- ANEB 28.4K
- Earning Date
- GTEC 11-13-2025
- ANEB 11-12-2025
- Dividend Yield
- GTEC N/A
- ANEB N/A
- EPS Growth
- GTEC N/A
- ANEB N/A
- EPS
- GTEC 0.53
- ANEB N/A
- Revenue
- GTEC $81,601,160.00
- ANEB N/A
- Revenue This Year
- GTEC $3.28
- ANEB N/A
- Revenue Next Year
- GTEC N/A
- ANEB N/A
- P/E Ratio
- GTEC $2.32
- ANEB N/A
- Revenue Growth
- GTEC N/A
- ANEB N/A
- 52 Week Low
- GTEC $1.14
- ANEB $0.80
- 52 Week High
- GTEC $2.92
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- GTEC 35.40
- ANEB 64.14
- Support Level
- GTEC $1.21
- ANEB $2.50
- Resistance Level
- GTEC $1.25
- ANEB $2.85
- Average True Range (ATR)
- GTEC 0.06
- ANEB 0.15
- MACD
- GTEC -0.01
- ANEB 0.04
- Stochastic Oscillator
- GTEC 3.92
- ANEB 83.87
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.